Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

December 31, 2012

Conditions
Malignant Mesothelioma
Interventions
DRUG

dasatinib

50 mg PO bid

Trial Locations (37)

13210

SUNY Upstate Medical University Hospital, Syracuse

19713

CCOP - Christiana Care Health Services, Newark

19958

Tunnell Cancer Center at Beebe Medical Center, Lewes

20007

Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C.

21237

Harry & Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center, Baltimore

21921

Union Hospital Cancer Program at Union Hospital, Elkton MD

24541

Danville Regional Medical Center, Danville

27534

Wayne Memorial Hospital, Incorporated, Goldsboro

27710

Duke Comprehensive Cancer Center, Durham

28501

Kinston Medical Specialists, Kinston

28677

Iredell Memorial Hospital, Statesville

29615

CCOP - Greenville, Greenville

46350

Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte

46515

Elkhart General Hospital, Elkhart

46601

CCOP - Northern Indiana CR Consortium, South Bend

Memorial Hospital of South Bend, South Bend

46617

Saint Joseph Regional Medical Center, South Bend

South Bend Clinic, South Bend

46845

Fort Wayne Medical Oncology and Hematology, Fort Wayne

46904

Howard Community Hospital, Kokomo

49085

Lakeland Regional Cancer Care Center - St. Joseph, Saint Joseph

55455

Masonic Cancer Center at University of Minnesota, Minneapolis

63131

Missouri Baptist Cancer Center, St Louis

63141

Arch Medical Services, Incorporated at Center for Cancer Care and Research, St Louis

68114

Methodist Estabrook Cancer Center, Omaha

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

92093-0658

Rebecca and John Moores UCSD Cancer Center, La Jolla

32803-1273

Florida Hospital Cancer Institute at Florida Hospital Orlando, Orlando

31403-3089

Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah

60637-1470

University of Chicago Cancer Research Center, Chicago

02114

Massachusetts General Hospital, Boston

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

08043

Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees Township

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

43210-1240

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus

05602

Mountainview Medical, Berlin Corners

05401

Fletcher Allen Health Care - University Health Center Campus, Burlington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00509041 - Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma | Biotech Hunter | Biotech Hunter